There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...
A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...
A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...
There are a total of 93 products in Phase I-III development for PD treatment. The Parkinson’s disease (PD) therapeutic ...
Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...
Live Science on MSN5d
E. coli in the gut may fuel a 'chain reaction' leading to Parkinson's, early study suggestsTwo recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.
According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...
The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback